Form 4 for CSTL CASTLE BIOSCIENCES INC
Accepted 2021-12-14 00:00:00 ET · period of report 2021-12-10 · accession 0001447362-21-000266 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-14 | 2021-12-10 | CSTL | MAETZOLD DEREK J | Pres, Chief Exec. Off, Dir | M - OptEx | — | +5,363 | 231.8K | +2% | — |
| D | 2021-12-14 | 2021-12-10 | CSTL | MAETZOLD DEREK J | Pres, Chief Exec. Off, Dir | F - Tax | $40.52 | -2,111 | 229.7K | -0.9% | -$85.5K |
| DM | 2021-12-14 | 2021-12-10 | CSTL | MAETZOLD DEREK J | Pres, Chief Exec. Off, Dir | A - Grant | $0.00 | +168.1K | 106.4K | New | $0 |
| D | 2021-12-14 | 2021-12-10 | CSTL | MAETZOLD DEREK J | Pres, Chief Exec. Off, Dir | M - OptEx | $0.00 | -5,363 | 16.1K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-10 | M | A | 5,363 | — | 231,790 | D | — | — | (F1) Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. (F2) On December 9, 2021, the Reporting Person transferred 75,000 shares of Castle Biosciences, Inc. common stock to the DJM Grantor Retained Annuity Trust No. 3 of which the Reporting Person is trustee and beneficiary. |
| 2 | Common | Common Stock | 2021-12-10 | F | D | 2,111 | $40.52 | 229,679 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2021-12-10 | A | A | 61,698 | $0.00 | 61,698 | D | — · — to — | 61,698 Common Stock | (F1) Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. (F7) The RSUs vest in four equal annual installments beginning on December 10, 2022. |
| 4 | Derivative | Stock option (right to buy) | 2021-12-10 | A | A | 106,376 | $0.00 | 106,376 | D | $40.52 · — to 2031-12-09 | 106,376 Common Stock | (F6) 25% of shares shall vest on December 10, 2022, and the remaining shares shall vest in 36 equal monthly installments thereafter. |
| 5 | Derivative | Restricted Stock Units | 2021-12-10 | M | D | 5,363 | $0.00 | 16,087 | D | — · — to — | 5,363 Common Stock | (F1) Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. (F8) On December 10, 2020, the Reporting Person was granted 21,450 RSUs, which vest in four equal annual installments beginning on December 10, 2021. |